187 related articles for article (PubMed ID: 22616003)
1. Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy.
Herrmann J; Elnakady YA; Wiedmann RM; Ullrich A; Rohde M; Kazmaier U; Vollmar AM; Müller R
PLoS One; 2012; 7(5):e37416. PubMed ID: 22616003
[TBL] [Abstract][Full Text] [Related]
2. Simplified pretubulysin derivatives and their biological effects on cancer cells.
Kubisch R; von Gamm M; Braig S; Ullrich A; Burkhart JL; Colling L; Hermann J; Scherer O; Müller R; Werz O; Kazmaier U; Vollmar AM
J Nat Prod; 2014 Mar; 77(3):536-42. PubMed ID: 24437936
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives.
Rath S; Liebl J; Fürst R; Ullrich A; Burkhart JL; Kazmaier U; Herrmann J; Müller R; Günther M; Schreiner L; Wagner E; Vollmar AM; Zahler S
Br J Pharmacol; 2012 Nov; 167(5):1048-61. PubMed ID: 22595030
[TBL] [Abstract][Full Text] [Related]
4. Pretubulysin, a potent and chemically accessible tubulysin precursor from Angiococcus disciformis.
Ullrich A; Chai Y; Pistorius D; Elnakady YA; Herrmann JE; Weissman KJ; Kazmaier U; Müller R
Angew Chem Int Ed Engl; 2009; 48(24):4422-5. PubMed ID: 19431172
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and antitumor activity evaluation of pretubulysin analogs.
Xu X; Fan M; Qi J; Yao L
Chem Biol Drug Des; 2021 Sep; 98(3):341-351. PubMed ID: 33930251
[TBL] [Abstract][Full Text] [Related]
6. Pretubulysin: a new option for the treatment of metastatic cancer.
Braig S; Wiedmann RM; Liebl J; Singer M; Kubisch R; Schreiner L; Abhari BA; Wagner E; Kazmaier U; Fulda S; Vollmar AM
Cell Death Dis; 2014 Jan; 5(1):e1001. PubMed ID: 24434509
[TBL] [Abstract][Full Text] [Related]
7. Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product.
Kaur G; Hollingshead M; Holbeck S; Schauer-Vukasinović V; Camalier RF; Dömling A; Agarwal S
Biochem J; 2006 Jun; 396(2):235-42. PubMed ID: 16489930
[TBL] [Abstract][Full Text] [Related]
8. The molecular pharmacology of symplostatin 1: a new antimitotic dolastatin 10 analog.
Mooberry SL; Leal RM; Tinley TL; Luesch H; Moore RE; Corbett TH
Int J Cancer; 2003 Apr; 104(4):512-21. PubMed ID: 12584751
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of tubulysin, an antimitotic peptide from myxobacteria.
Khalil MW; Sasse F; Lünsdorf H; Elnakady YA; Reichenbach H
Chembiochem; 2006 Apr; 7(4):678-83. PubMed ID: 16491500
[TBL] [Abstract][Full Text] [Related]
10. Pretubulysin derived probes as novel tools for monitoring the microtubule network via activity-based protein profiling and fluorescence microscopy.
Eirich J; Burkhart JL; Ullrich A; Rudolf GC; Vollmar A; Zahler S; Kazmaier U; Sieber SA
Mol Biosyst; 2012 Aug; 8(8):2067-75. PubMed ID: 22722320
[TBL] [Abstract][Full Text] [Related]
11. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.
Jiang JD; Davis AS; Middleton K; Ling YH; Perez-Soler R; Holland JF; Bekesi JG
Cancer Res; 1998 Dec; 58(23):5389-95. PubMed ID: 9850070
[TBL] [Abstract][Full Text] [Related]
12. Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli. Production, isolation, physico-chemical and biological properties.
Sasse F; Steinmetz H; Heil J; Höfle G; Reichenbach H
J Antibiot (Tokyo); 2000 Sep; 53(9):879-85. PubMed ID: 11099220
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
14. The tubulysin analogue KEMTUB10 induces apoptosis in breast cancer cells via p53, Bim and Bcl-2.
Lamidi OF; Sani M; Lazzari P; Zanda M; Fleming IN
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1575-83. PubMed ID: 25633717
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 23 natural tubulysins from Angiococcus disciformis An d48 and Cystobacter SBCb004.
Chai Y; Pistorius D; Ullrich A; Weissman KJ; Kazmaier U; Müller R
Chem Biol; 2010 Mar; 17(3):296-309. PubMed ID: 20338521
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Evaluation of Biological Properties of 2-Amino-thiazole-4-carboxamides: Amide Linkage Analogues of Pretubulysin.
Ouyang B; Wang L; Qi J; Fan M; Wang H; Yao L
Biol Pharm Bull; 2020; 43(8):1154-1158. PubMed ID: 32741936
[TBL] [Abstract][Full Text] [Related]
17. A simplified synthesis of novel dictyostatin analogues with in vitro activity against epothilone B-resistant cells and antiangiogenic activity in zebrafish embryos.
Vollmer LL; Jiménez M; Camarco DP; Zhu W; Daghestani HN; Balachandran R; Reese CE; Lazo JS; Hukriede NA; Curran DP; Day BW; Vogt A
Mol Cancer Ther; 2011 Jun; 10(6):994-1006. PubMed ID: 21490306
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic. Arrest, apoptosis, and microtubule assembly in human breast cancer cells.
MacCarthy-Morrogh L; Townsend PA; Purohit A; Hejaz HAM ; Potter BVL ; Reed MJ; Packham G
Cancer Res; 2000 Oct; 60(19):5441-50. PubMed ID: 11034086
[TBL] [Abstract][Full Text] [Related]
19. Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin.
Kuznetsov G; TenDyke K; Towle MJ; Cheng H; Liu J; Marsh JP; Schiller SE; Spyvee MR; Yang H; Seletsky BM; Shaffer CJ; Marceau V; Yao Y; Suh EM; Campagna S; Fang FG; Kowalczyk JJ; Littlefield BA
Mol Cancer Ther; 2009 Oct; 8(10):2852-60. PubMed ID: 19825803
[TBL] [Abstract][Full Text] [Related]
20. 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules.
Kamath K; Okouneva T; Larson G; Panda D; Wilson L; Jordan MA
Mol Cancer Ther; 2006 Sep; 5(9):2225-33. PubMed ID: 16985056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
